Optimized models can personalize predictions for patients with prostate, breast and other cancers
Treatment addresses endocrine resistance
Lack of appropriate testing remains a barrier for patients eligible for targeted treatment
Fine-tuning radiation for recurrent cancers
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Early interventions, improved screening access and tailored support services can help patients navigate cancer care
Dedicated investigators and clinicians bring expertise in drug development and flexible study design
Retrospective study aims to better stratify risk of disease recurrence
Timely referral to hospice care reduces emergency room admissions
62% of patients were progression-free at 18 months post-transplantation
Study assesses the impact of donor source and post-transplant prophylaxis for patients receiving a hematopoietic cell transplant
Advertisement
Advertisement